PlainRecalls
FDA Drug Critical Class I Terminated

Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL Carpuject Single-use cartridge syringe, Single unit (NDC 0409-1782-03) and 10 count box (NDC 0409-1782-69), Rx Only, Hospira Inc., Lake Forest, IL

Reported: June 13, 2018 Initiated: June 4, 2018 #D-0906-2018

Product Description

Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL Carpuject Single-use cartridge syringe, Single unit (NDC 0409-1782-03) and 10 count box (NDC 0409-1782-69), Rx Only, Hospira Inc., Lake Forest, IL

Reason for Recall

Presence of Particulate Matter; Potential for particulate matter on the syringe plunger.

Details

Recalling Firm
HOSPIRA INC, LAKE FOREST
Units Affected
164,860 syringes
Distribution
Nationwide in the U.S., Puerto Rico, and Guam
Location
LAKE FOREST, IL

Frequently Asked Questions

What product was recalled?
Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL Carpuject Single-use cartridge syringe, Single unit (NDC 0409-1782-03) and 10 count box (NDC 0409-1782-69), Rx Only, Hospira Inc., Lake Forest, IL. Recalled by HOSPIRA INC, LAKE FOREST. Units affected: 164,860 syringes.
Why was this product recalled?
Presence of Particulate Matter; Potential for particulate matter on the syringe plunger.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 13, 2018. Severity: Critical. Recall number: D-0906-2018.